Mesa Laboratories, Inc.
MLAB
$98.67
$2.312.40%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 97.21% | -179.21% | 378.70% | 717.12% | -41,766.61% |
| Total Depreciation and Amortization | 19.09% | -39.25% | -25.05% | -32.81% | -24.75% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -98.97% | 2,237.21% | -58.25% | -44.90% | 16,399.67% |
| Change in Net Operating Assets | 13.14% | 3,559.22% | -342.34% | 70.01% | 325.50% |
| Cash from Operations | -1.69% | 59.85% | -46.08% | 4.97% | 2.91% |
| Capital Expenditure | -41.50% | 27.93% | -182.02% | -230.00% | 47.86% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -336.38% | 98.99% | -182.02% | -230.00% | 141.52% |
| Total Debt Issued | -- | -100.00% | -- | -- | -- |
| Total Debt Repaid | -55.98% | -8.31% | -48.74% | -908.60% | -91.67% |
| Issuance of Common Stock | 638.55% | -- | -- | -- | -85.53% |
| Repurchase of Common Stock | -21.84% | -- | -- | -- | -7,180.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.69% | -0.81% | -0.46% | -0.47% | -0.93% |
| Other Financing Activities | 531.16% | 106.90% | -201.66% | -55.00% | -- |
| Cash from Financing | -25.21% | -117.42% | -54.86% | 4.31% | -194.47% |
| Foreign Exchange rate Adjustments | 333.16% | -138.97% | 390.91% | 74.42% | -32.19% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -36,250.00% | 189.53% | -227.58% | 148.31% | -100.15% |